Advanced Search


Study ID Status Title Patient Level Data
201133 Completed A methodology study to evaluate a sitting knee measuring device in assessing growth in Indian children aged 6 to 12 years receiving nutritional supplement with or without micronutrient fortification
201135 Completed 201135 : A Randomised, Double-blind, Multicenter, Parallel-group Study to Compare the Efficacy and Safety of Fluticasone Furoate (FF) 100 mcg Once Daily with Fluticasone Propionate (FP) 250 mcg Twice Daily (BD) and FP 100 mcg BD in Well-controlled Asthmatic Subjects Stepped Down from a Maintenance Therapy with RELVAR® inhaler (FF/VI) 100/25 mcg Once-daily in Japanese Subjects Study Listed on
201137 Active not recruiting An Evaluation of DCE-MRI measures of Pulmonary Oedema and Vascular Permeability in Healthy Subjects and in Patients with Cardiac Failure: A Methods Validation Study for Evaluation of Novel Treatments Limiting Pulmonary Oedema in Cardiac Failure
201147 Completed 201147: a Phase IIIb, randomized, open-label study of the safety, efficacy, and tolerability of switching to a fixed-dose combination of abacavir/dolutegravir/ lamivudine from current antiretroviral regimen compared with continuation of the current antiretroviral regimen in HIV-1 infected adults who are virologically suppressed, The STRIIVING Study.
201152 Active not recruiting Indirect treatment comparisons of Ph3 combination studies for dabrafenib plus trametinib versus other treatments
201153 Completed Updated analyses adjusting for treatment crossover in Part C of a Phase 2 trial (BRF113220) of dabrafenib and trametinib combination therapy in patients with metastatic melanoma based on recent dataset (March 2013)
201156 Not yet recruiting Prostate Research On Behaviour & Education (PROBE II) Survey. Cross-sectional, multinational, qualitative study to explore and identify patient and healthcare provider attitudes to benign prostatic hyperplasia in Asia Pacific, Latin America, and Commonwealth of Independent States (CIS)
201159 Completed A Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate the Effect of 12 weeks of Once-daily Dosing of the Oral Motilin Receptor Agonist Camicinal, on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects with Gastroparesis
201167 Completed A Phase I, open label, parallel group, three period, fixed sequence crossover study to evaluate the effect of dolutegravir on metformin pharmacokinetics in healthy adult subjects
201177 Active not recruiting PRJ2203: A Prospective Observational Cohort Study to Monitor Occurrence of Hypersensitivity Reaction and Hepatotoxicity in Patients Receiving Dolutegravir
201182 Completed Meta-Analysis Plan for Study Number 201182, GSK1550188, SLE, Pregnancy Analysis
201186 Completed Utilization of Rosiglitazone in Triple Therapy and Insulin Combinations and Estimated Rates of Adverse Events in Rosiglitazone Recipients in Canada, 2011-2012
201187 Withdrawn A randomized, double-blind, placebo-controlled Phase II study of pazopanib versus placebo as maintenance therapy for patients who have not progressed after first-line chemotherapy for advanced soft tissue sarcoma (STS)
201188 Completed PGx7529: Exploratory Pharmacogenetic evaluation of Potential Modifiers of Duchenne Muscular Dystrophy patient response to Drisapersen
201190 Recruiting Efficacy, safety and immunogenicity of GSK Biologicals’ HZ/su vaccine GSK1437173A in a phase IIIb, open-label, long-term follow-up study (ZOE-LTFU) of studies 110390/113077 (ZOSTER-006/022) and assessment of additional doses in older adults
201191 Active not recruiting A Prospective and Retrospective Observational Study of Real-World Treatment Patterns in Patients with HER2+Advanced or Metastatic Breast Cancer in Europe and the United States
201198 Active not recruiting Immunogenicity and safety study of GSK Biologicals’ Herpes Zoster vaccine GSK1437173A in adults ≥ 65 years of age with and without Zostavax® vaccination at least 5 years earlier
201203 Not yet recruiting The burden of illness among patients with stage I-IIIA HER2+ breast cancer who undergo surgical resection and adjuvant therapy
201211 Completed A 12 week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy of Umeclidinium/Vilanterol 62.5/25mcg in Subjects with COPD Study Listed on
201212 Recruiting A Phase I, Open-Label Study of GSK3174998 Administered Alone and in Combination with Anticancer Agents including Pembrolizumab in Subjects with Selected Advanced Solid Tumors
201213 Active not recruiting A Prospective, Multi-center, Cohort Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) Therapy in Chinese Chronic Hepatitis B (CHB) Subjects with Advanced Fibrosis & Compensated Cirrhosis
201215 Active not recruiting A multi-centre, single-arm, open-label study to evaluate the efficacy and safety of Tenofovir Disoproxil Fumarate(TDF) treatment in Chinese chronic hepatitis B (CHB) subjects following failure of multiple Nucleos(t)ide analogues(NAs)
201216 Active not recruiting PGx7521: Evaluation of validated HLA markers with DILI in lapatinib clinical trial EGF106903
201222 Active not recruiting A Phase I/II clinical trial of hematopoietic stem cell gene therapy for the treatment of Metachromatic Leukodystrophy
201223 Active not recruiting Study 201223 - Interim Meta-analysis of BEL112233, BEL112234, BEL110751 and BEL110752



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.